Jennifer McNealey | VP, IR & Strategy |
Susan Molineaux | Co-Founder, CEO, President & Director |
Keith Orford | Chief Medical Officer |
Stephanie Wong | SVP, Finance & Secretary |
Jonathan Chang | SVB Leerink |
Mohit Bansal | Citigroup |
Matthew Phipps | William Blair & Company |
Nicholas Abbott | Wells Fargo Securities |
Good day, ladies and gentlemen. Thank you for standing by, and welcome to Calithera Biosciences Second Quarter 2019 Earnings Conference Call. [Operator Instructions].
As a reminder, this conference may be recorded. At this time, I would like to turn the conference call over to Jennifer McNealey.